Sebacic Acid

Sebacic Acid

SCHEMBL7179944

CC1(C)CCCC(C)(C)N1O.CC1(C)CCCC(C)(C)N1O.O=C(O)CCCCCCCCC(=O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.46
LMNA P02545 2/20 0.46
NFKB1 P19838 1/20 0.46
PMP22 Q01453 1/20 0.46
GPR84 Q9NQS5 8/20 0.43
PPARG P37231 7/20 0.43
PPARD Q03181 7/20 0.43
PPARA Q07869 7/20 0.43
HDAC11 Q96DB2 5/20 0.43
PTPN1 P18031 3/20 0.43
ALDH1A1 P00352 3/20 0.43
TLR2 O60603 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
FABP4 P15090 2/20 0.43
FFAR1 O14842 2/20 0.43
FFAR4 Q5NUL3 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
MEN1 O00255 1/20 0.43
ESR1 P03372 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Octanedioate SCHEMBL30741313 1.00 TSHR (0.46) TSHRLMNANFKB1PMP22GPR84
Sebacic Acid SCHEMBL28325940 1.00 TSHR (0.46) TSHRLMNANFKB1PMP22GPR84
Sebacic Acid SCHEMBL480504 0.85 TSHR (0.46) TSHRLMNANFKB1PMP22GPR84
Sebacic Acid SCHEMBL8958570 0.85 TSHR (0.56) TSHRLMNANFKB1PMP22GPR84
SCHEMBL4453278 0.81 TSHR (0.43) TSHRLMNANFKB1PMP22GPR84
Stearic Acid SCHEMBL22190074 0.79 GPR84 (0.57) TSHRLMNANFKB1GPR84PPARG
Sebacic Acid SCHEMBL28583209 0.79 GPR84 (0.44) TSHRLMNANFKB1PMP22GPR84
Sebacic Acid SCHEMBL28431715 0.78 TSHR (0.43) TSHRLMNANFKB1PMP22GPR84
Sebacic Acid SCHEMBL6935403 0.78 TSHR (0.43) TSHRLMNANFKB1PMP22GPR84
SCHEMBL11068931 0.78 ADRA1A (0.47) TSHRLMNANFKB1PMP22GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114196110-A Film-grade polypropylene coloring master batch and preparation method thereof 江阴市得宝新材料科技有限公司 2022-03-18 CN claimed
EP-3077420-A1 NITROXIDE HYDROXYLAMINE AND PHENYLENEDIAMINE COMBINATIONS AS POLYMERIZATION INHIBITORS FOR ETHYLENICALLY UNSATURATED MONOMER PROCESSES Ecolab USA Inc. (US) 2016-10-12 EP claimed
WO-2015084843-A1 NITROXIDE HYDROXYLAMINE AND PHENYLENEDIAMINE COMBINATIONS AS POLYMERIZATION INHIBITORS FOR ETHYLENICALLY UNSATURATED MONOMER PROCESSES ECOLAB USA INC. (US) 2015-06-11 WO claimed
US-20150152053-A1 NITROXIDE HYDROXYLAMINE AND PHENYLENEDIAMINE COMBINATIONS AS POLYMERIZATION INHIBITORS FOR ETHYLENICALLY UNSATURATED MONOMER PROCESSES Ecolab USA, Inc. (US) 2015-06-04 US claimed
US-20250340794-A1 COMPOSITION WITH FATTY ACID DERIVATIVES AND USE IN INDUSTRIAL PROCESSES ECOLAB USA INC (US) 2025-11-06 US disclosed
CN-114196110-A Film-grade polypropylene coloring master batch and preparation method thereof 江阴市得宝新材料科技有限公司 2022-03-18 CN disclosed
US-11186540-B2 Anti-foulant formulation for compressors ECOLAB USA INC. (US) 2021-11-30 US disclosed
CN-110337488-B Antifouling agent formulation for compressor 埃科莱布美国股份有限公司 2021-11-16 CN disclosed
CN-108752502-B Nitroxide hydroxylamine and phenylenediamine combinations as polymerization inhibitors for ethylenically unsaturated monomer processes 艺康美国股份有限公司 2021-10-29 CN disclosed
CN-110483931-B Polyacrylate polymer composite material and preparation method thereof 金发科技股份有限公司 2021-09-17 CN disclosed
CN-112724071-A Preparation method and equipment of hindered amine light stabilizer 浙江合糖科技有限公司 2021-04-30 CN disclosed
EP-3425001-B1 CYCLIC OLEFIN COPOLYMER COMPOSITION AND CROSSLINKED PRODUCT THEREOF MITSUI CHEMICALS INC (JP) 2021-03-24 EP disclosed
WO-2018156914-A1 ANTI-FOULANT FORMULATION FOR COMPRESSORS Ecolab USA, Inc. (US) 2018-08-30 WO disclosed
EP-3077420-A1 NITROXIDE HYDROXYLAMINE AND PHENYLENEDIAMINE COMBINATIONS AS POLYMERIZATION INHIBITORS FOR ETHYLENICALLY UNSATURATED MONOMER PROCESSES Ecolab USA Inc. (US) 2016-10-12 EP disclosed
US-20160244398-A1 NITROXIDE HYDROXYLAMINE AND PHENYLENEDIAMINE COMBINATIONS AS POLYMERIZATION INHIBITORS FOR ETHYLENICALLY UNSATURATED MONOMER PROCESSES Ecolab USA, Inc. (US) 2016-08-25 US disclosed
US-9399622-B2 Nitroxide hydroxylamine and phenylenediamine combinations as polymerization inhibitors for ethylenically unsaturated monomer processes ECOLAB USA INC. (US) 2016-07-26 US disclosed
WO-2015084843-A1 NITROXIDE HYDROXYLAMINE AND PHENYLENEDIAMINE COMBINATIONS AS POLYMERIZATION INHIBITORS FOR ETHYLENICALLY UNSATURATED MONOMER PROCESSES ECOLAB USA INC. (US) 2015-06-11 WO disclosed
US-20150152053-A1 NITROXIDE HYDROXYLAMINE AND PHENYLENEDIAMINE COMBINATIONS AS POLYMERIZATION INHIBITORS FOR ETHYLENICALLY UNSATURATED MONOMER PROCESSES Ecolab USA, Inc. (US) 2015-06-04 US disclosed
EP-0953596-B1 Automobile interior or exterior trim material ASAHI DENKA KOGYO KK (JP) 2003-10-29 EP disclosed
EP-0953596-A2 Automobile interior or exterior trim material ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1999-11-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150152053-A1 NITROXIDE HYDROXYLAMINE AND PHENYLENEDIAMINE COMBINATIONS AS POLYMERIZATION INHIBITORS FOR ETHYLENICALLY UNSATURATED MONOMER PROCESSES PNMT, NOS1, HPGD TSHR 4694/4885LMNA 1012/4885NFKB1 856/4885
US-20160244398-A1 NITROXIDE HYDROXYLAMINE AND PHENYLENEDIAMINE COMBINATIONS AS POLYMERIZATION INHIBITORS FOR ETHYLENICALLY UNSATURATED MONOMER PROCESSES PNMT, NOS1, HPGD TSHR 4694/4885LMNA 1012/4885NFKB1 856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.